Glucosephosphate Dehydrogenase
"Glucosephosphate Dehydrogenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D005954
|
| MeSH Number(s) |
D08.811.682.047.150.300
|
| Concept/Terms |
Glucosephosphate Dehydrogenase- Glucosephosphate Dehydrogenase
- Dehydrogenase, Glucosephosphate
- Glucose-6-Phosphate Dehydrogenase
- Dehydrogenase, Glucose-6-Phosphate
- Glucose 6 Phosphate Dehydrogenase
|
Below are MeSH descriptors whose meaning is more general than "Glucosephosphate Dehydrogenase".
Below are MeSH descriptors whose meaning is more specific than "Glucosephosphate Dehydrogenase".
This graph shows the total number of publications written about "Glucosephosphate Dehydrogenase" by people in this website by year, and whether "Glucosephosphate Dehydrogenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucosephosphate Dehydrogenase" by people in Profiles.
-
Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model. PLoS Med. 2024 Jan; 21(1):e1004255.
-
Hemolysis After Medication Exposure in Pediatric Patients With G6PD Deficiency. J Pediatr Hematol Oncol. 2022 07 01; 44(5):261-263.
-
G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19. Pharmacogenomics J. 2021 12; 21(6):649-656.
-
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. Pediatr Blood Cancer. 2019 06; 66(6):e27681.
-
Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. Am J Hematol. 2013 Jul; 88(7):571-6.
-
Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011 Jun 16; 117(24):6681-4.
-
Prevalence of G6PD deficiency in a large cohort of HIV-infected patients. J Infect. 2010 Nov; 61(5):399-402.
-
A novel G6PD mutation leading to chronic hemolytic anemia. Pediatr Blood Cancer. 2008 Dec; 51(6):816-9.
-
Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient. Pediatr Blood Cancer. 2008 Oct; 51(4):568.
-
Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals. Diabetes. 2006 Nov; 55(11):2939-49.